Synapse - Works

Results (4760)

Carfilzomib plus high dose melphalan conditioning prior to autologous hematopoietic cell transplantation followed by carfilzomib maintenance in patients with relapsed multiple myeloma

Meeting Abstract

Costa, L. J.; Landau, H.; Chhabra, S.; Hari, P.; Salzman, D.; Saad, A.; Innis-Shelton, R.; Hamadani, M.; Tamari, R.; Godby, K. N.; more...
Blood (2016)

Fulltext@MSK | Save

Novel associations between mutations, prognostic and clinical parameters in untreated progressive CLL: Data from E1912, a randomized phase III study of the ECOG-ACRIN Cancer Research Group

Meeting Abstract

Braggio, E.; Wang, V. X.; Garcia, S.; Bruins, L. A.; Lesnick, C.; Barrientos, J. C.; O'Brien, S. M.; Tallman, M. S.; Fonseca, R.; Kay, N. E.; more...
Blood (2016)

Fulltext@MSK | Save

Safety and activity of brentuximab vedotin (BV) plus ifosfamide, carboplatin, and etoposide (ICE) for relapsed/refractory (Rel/Ref) classical Hodgkin lymphoma (cHL): Initial results of a phase I/II trial

Meeting Abstract

Cassaday, R. D.; Fromm, J.; Cowan, A. J.; Libby, E. N. 3rd; Philip, M.; Behnia, S.; Nartea, M.; Press, O.; Gopal, A. K.
Blood (2016)

Fulltext@MSK | Save

Enhancing cytotoxicity of autologous T cells in AML by blockade of CTLA-4 and PD-1

Meeting Abstract

Boughan, K. M.; Chen, X.; Szabolcs, P.
Blood (2016)

Fulltext@MSK | Save

The Disease Risk Index predicts outcomes including relapse and survival in CD34-selected allogeneic HCT for acute leukemia and myelodysplastic syndrome

Meeting Abstract

Cho, C.; Hilden, P.; Peled, J. U.; Avecilla, S. T.; Barba, P.; Barker, J. N.; Castro-Malaspina, H. R.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; more...
Blood (2016)

Fulltext@MSK | Save

A phase 1b study investigating carfilzomib administered once weekly in combination with lenalidomide and dexamethasone in patients with multiple myeloma

Meeting Abstract

Biran, N.; Siegel, D. S.; Berdeja, J. G.; Faber, E.; Seneviratne, L.; Alsina, M.; Bensinger, W.; Kimball, A. S.; Zhou, K.; Landgren, O.
Blood (2016)

Fulltext@MSK | Save

HCT outcome in patients with Fanconi anemia transplanted at adult age

Meeting Abstract

Bierings, M.; Bonfim, C.; De La Tour, R. P.; Aljurf, M.; Mehta, P. A.; Knol, C.; Boulad, F.; Tbakhi, A.; Esquirol, A.; McQuaker, G.; more...
Blood (2016)

Fulltext@MSK | Save

Defined central memory and stem memory T cell phenotype of CD4 and CD8 CAR T cells for the treatment of CD19+ acute lymphoblastic leukemia in an automated closed system

Meeting Abstract

Blaeschke, F.; Kaeuferle, T.; Feucht, J.; Weber, D.; Lotfi, R.; Kaiser, A.; Assenmacher, M.; Doering, M.; Feuchtinger, T.
Blood (2016)

Fulltext@MSK | Save

A phase I/II open-label, dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in subjects with relapsed, refractory hematologic malignancies

Meeting Abstract

Borthakur, G.; Dawson, M. A.; Stein, E. M.; Karadimitris, A.; Huntly, B. J. P.; Dickinson, M. J.; Chaidos, A.; Horner, T.; Brennan, J.; Baron, J.; more...
Blood (2016)

Fulltext@MSK | Save

The selective anti leukemic effect of BL-8040, a peptidic CXCR4 antagonist, is mediated by induction of leukemic blast mobilization, differentiation and apoptosis: Results of correlative studies from a Ph2a trial in acute myeloid leukemia

Meeting Abstract

Borthakur, G.; Tallman, M. S.; Ofran, Y.; Foran, J. M.; Uy, G. L.; DiPersio, J. F.; Nagler, A.; Rowe, J. M.; Showel, M. M.; Altman, J.; more...
Blood (2016)

Fulltext@MSK | Save